The effect of omeprazole on oesophageal pH in dogs during anaesthesia.
Panti A, Bennett RC, Corletto F, Brearley J, Jeffery N, Mellanby RJ.
J Small Anim Pract · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1748-5827.2009.00818.x PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för omeprazole. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
66 hitsNanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders.
Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S.
Chem Pharm Bull (Tokyo) · journal article · DOI 10.1248/cpb.57.1050Negative chronotropic effect of proton pump inhibitors on frog-heart preparation.
Gautam CS, Utreja A, Goel D, Sandhu G, Gogia N.
Indian J Gastroenterol · journal article · DOI 10.1007/s12664-009-0052-xDrug-drug interaction between clopidogrel and the proton pump inhibitors.
Norgard NB, Mathews KD, Wall GC.
Ann Pharmacother · review; journal article · DOI 10.1345/aph.1m051Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
Ho KY, Kuan A, Zaño F, Goh KL, Mahachai V, Kim DY, Yoon HM.
J Gastroenterol · comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1007/s00535-009-0072-4Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
Can J Clin Pharmacol · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article[Antiangiogenic activity of thalidomide in vitro mediated by cytochrome CYP2C19].
Li YH, Hou J, Jiang H, Huang HM.
Zhongguo Shi Yan Xue Ye Xue Za Zhi · journal articleBioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
Joti JJ, Nahar K, Hasan A, Azad MA, Ullah MA, Islam SM, Hasnat A.
Arzneimittelforschung · comparative study; randomized controlled trial; journal article · DOI 10.1055/s-0031-1296382Analysis of omeprazole and its main metabolites by liquid chromatography using hybrid micellar mobile phases.
Rambla-Alegre M, Esteve-Romero J, Carda-Broch S.
Anal Chim Acta · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.aca.2008.11.059[Effect of cytochrome CYP2C19 on the anti-myeloma activity of thalidomide in vitro].
Li YH, Hou J, Jiang H, Huang HM, Zhu R.
Zhonghua Xue Ye Xue Za Zhi · journal articleOmeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells.
Shiizaki K, Ohsako S, Kawanishi M, Yagi T.
Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1742-7843.2008.00309.xAssociation between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.
Sultan N, Nazareno J, Gregor J.
Can J Gastroenterol · meta-analysis; research-article; systematic review; journal article · DOI 10.1155/2008/821385[Drug-drug interactions in patients from an internal medicine service].
Ibáñez A, Alcalá M, García J, Puche E.
Farm Hosp · journal article; english abstract · DOI 10.1016/s1130-6343(08)75950-6Melatonin for the treatment of gastroesophageal reflux disease.
Werbach MR.
Altern Ther Health Med · review; journal article; case reportsEvaluation of use of proton pump inhibitors in Greece.
Ntaios G, Chatzinikolaou A, Kaiafa G, Savopoulos C, Hatzitolios A, Karamitsos D.
Eur J Intern Med · journal article · DOI 10.1016/j.ejim.2007.10.020The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.
Uno T, Sugimoto K, Sugawara K, Tateishi T.
Ther Drug Monit · randomized controlled trial; journal article · DOI 10.1097/ftd.0b013e31816e2d8eValidation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
Campbell CA, Gaskin PJ, Darton J, Chiu P, Lee K, McLean PG.
Eur J Pharmacol · comparative study; validation study; journal article · DOI 10.1016/j.ejphar.2008.05.026Omeprazole promotes gastric epithelial cell migration.
Ng KM, Cho CH, Chang FY, Luo JC, Lin HC, Lin HY, Chi CW, Lee SD.
J Pharm Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1211/jpp.60.5.0012[Acute generalized exanthematous pustulosis induced by omeprazole].
Nantes Castillejo O, Zozaya Urmeneta JM, Valcayo Peñalba A, Martínez-Peñuela Virseda JM.
Gastroenterol Hepatol · journal article; english abstract; case reports · DOI 10.1157/13119883Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.
Poo JL, Galán JF, Rosete A, de Lago A, Oliva I, González-de la Parra M, Jiménez P, Burke-Fraga V, Namur S.
Clin Ther · clinical trial, phase ii; comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2008.04.004Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers.
Baldwin RM, Ohlsson S, Pedersen RS, Mwinyi J, Ingelman-Sundberg M, Eliasson E, Bertilsson L.
Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1111/j.1365-2125.2008.03104.xSafety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England.
Davies M, Wilton LV, Shakir SA.
Drug Saf · research support, non-u.s. gov't; journal article · DOI 10.2165/00002018-200831040-00005Analytical methodologies for the determination of omeprazole: an overview.
Espinosa Bosch M, Ruiz Sánchez AJ, Sánchez Rojas F, Bosch Ojeda C.
J Pharm Biomed Anal · review; journal article · DOI 10.1016/j.jpba.2007.04.022Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R, Singh R, Dogra M, Garg S.
N Z Med J · research support, non-u.s. gov't; journal articleReactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole.
Tutunji MF, Qaisi AM, El-Eswed BI, El-Eswed BI, Tutunji LF.
J Pharm Sci · journal article · DOI 10.1002/jps.20588[Anaphylaxis caused by omeprazole].
Kamann S, Bauer C, Fackler I, Przybilla B.
Hautarzt · comparative study; journal article; english abstract; case reports · DOI 10.1007/s00105-005-1076-5Semipreparative enantiomeric separation of omeprazole by supercritical fluid chromatography.
Toribio L, Alonso C, del Nozal MJ, Bernal JL, Martín MT.
J Chromatogr A · research support, non-u.s. gov't; journal article · DOI 10.1016/j.chroma.2006.09.092Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE).
Qaisi AM, Tutunji MF, Tutunji LF.
J Pharm Sci · journal article · DOI 10.1002/jps.20546Anaphylaxis to omeprazole: diagnosis and desensitization protocol.
Confino-Cohen R, Goldberg A.
Ann Allergy Asthma Immunol · journal article; case reports · DOI 10.1016/s1081-1206(10)61037-xReview of immediate-release omeprazole for the treatment of gastric acid-related disorders.
Castell D.
Expert Opin Pharmacother · comparative study; review; journal article · DOI 10.1517/14656566.6.14.2501